美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Faeth Therapeutics

37.44

-1.5600-4.00%

盤後：37.440.00000.00%19:30 EDT

成交量：37.71萬

成交額：1,433.86萬

市值：9.65億

市盈率：-0.26

高：40.50

開：39.08

低：36.31

收：39.00

52周最高：42.14

52周最低：7.45

股本：2,577.88萬

流通股本：81.17萬

量比：1.39

換手率：46.46%

股息：- -

股息率：- -

每股收益(TTM):-141.6499

每股收益(LYR):-16.7239

淨資產收益率：-195.26%

總資產收益率：-20.79%

市淨率：5.58

市盈率(LYR):-2.24

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Faeth Therapeutics

交易所：

NASDAQ

成立時間：

1999

員工人數：

29

公司地址：

1405 Research Boulevard,Suite 125,Rockville,Maryland,United States

官網：

http://www.faeththerapeutics.com

郵編：

20850

電話：

傳真：

- -

簡介：

Faeth Therapeutics, Inc.是一家臨床階段的免疫療法公司，於2017年12月1日在特拉華州註冊成立。該公司是一家免疫腫瘤學公司，專註於癌症患者下一代療法的發現和開發。通過TMAb（腫瘤微環境激活生物製劑）平台，公司正在開發高選擇性療法，旨在在腫瘤微環境中選擇性地禁用免疫抑制信號或激活免疫刺激信號，以釋放T細胞對抗腫瘤。

董事

名稱

職位

Bob Holmen

Director

Karen Vousden

Director

Kristian Humer

Director

Phillip B. Donenberg

Director

Saira Ramasastry

Director

Stephen M. Hahn

Director

Thomas Ricks

Director

股東

名稱

職位

Anand Parikh

Chief Operating Officer

Josiah Craver

Principal Financial and Accounting Officer and Senior Vice President of Finance

Brian Stephenson

Head of Operations and Finance

Christopher W. Gerry

General Counsel and President

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/FTH/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","market":"US","secType":"STK","nameCN":"Faeth Therapeutics","latestPrice":37.44,"timestamp":1789156800000,"preClose":39,"halted":0,"volume":377119,"hourTrading":{"tag":"盘后","latestPrice":37.44,"preClose":37.44,"latestTime":"19:30 EDT","volume":929,"amount":34772.58,"timestamp":1789169405030,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.040000000000000056,"floatShares":811700,"shares":25778800,"eps":-141.6499,"marketStatus":"休市中","change":-1.56,"latestTime":"09-11 16:00:00 EDT","open":39.08,"high":40.5,"low":36.31,"amount":14338626.28731,"amplitude":0.107436,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-141.6499,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1612414800000,"exchange":"NASDAQ","adjPreClose":39,"preHourTrading":{"tag":"盘前","latestPrice":39.01,"preClose":39,"latestTime":"07:00 EDT","volume":20,"amount":780.1999999999999,"timestamp":1789124400227,"change":0.01,"changeRate":0.000256,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":37.44,"preClose":37.44,"latestTime":"19:30 EDT","volume":929,"amount":34772.58,"timestamp":1789169405030,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3880703379495405},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","floatShares":811700,"roa":"-20.79%","roe":"-195.26%","lyrEps":-16.72388,"volumeRatio":1.3880703379495405,"shares":25778800,"dividePrice":0,"high":40.5,"amplitude":0.107436,"preClose":39,"low":36.31,"week52Low":7.45,"pbRate":"5.58","week52High":42.1431,"institutionHeld":0,"latestPrice":37.44,"eps":-141.6499,"divideRate":0,"volume":377119,"delay":0,"ttmEps":-141.6499,"open":39.08,"prevYearClose":10.67,"prevWeekClose":40.05,"prevMonthClose":32.77,"prevQuarterClose":25,"fiveDayClose":39,"twentyDayClose":28.55,"sixtyDayClose":14.53},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"FTH","fiscalQuarterEnding":"2026/06","expectedEps":-1.1,"name":null,"time":"盤前","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-2.84},{"market":"US","date":"2026-05-15","symbol":"FTH","fiscalQuarterEnding":"2026/03","expectedEps":-0.62,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-131.45},{"market":"US","date":"2026-03-30","symbol":"FTH","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-3.74},{"market":"US","date":"2025-11-14","symbol":"FTH","fiscalQuarterEnding":"2025/09","expectedEps":-4.11,"name":null,"time":"盤前","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-3.62},{"market":"US","date":"2025-08-05","symbol":"FTH","fiscalQuarterEnding":"2025/06","expectedEps":-6.2,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-3.91}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.5833,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":12,"updateTime":1789012800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FTH","date":"2026-09-11","current":-0.264314,"percent":0.051724,"low":-5.292894,"twenty":-4.552871,"median":-3.964844,"eighty":-3.358825,"high":-0.105707,"avg":-3.808203,"sd":1.140923,"marketCap":1007776575},"quantilePoints":[{"date":"2026-06-18","current":-0.12113,"twenty":-0.118045,"median":-0.113419,"eighty":-0.108792,"marketCap":22343317},{"date":"2026-06-26","current":-3.447751,"twenty":-3.41449,"median":-0.168709,"eighty":-0.122832,"marketCap":635961861},{"date":"2026-07-02","current":-3.306599,"twenty":-3.429583,"median":-3.245107,"eighty":-0.129642,"marketCap":609925319},{"date":"2026-07-10","current":-4.547622,"twenty":-3.49387,"median":-3.330357,"eighty":-0.168709,"marketCap":838840655},{"date":"2026-07-17","current":-3.62524,"twenty":-4.398084,"median":-3.429583,"eighty":-3.196193,"marketCap":668700878},{"date":"2026-07-24","current":-3.879594,"twenty":-4.005373,"median":-3.554664,"eighty":-3.20318,"marketCap":715618211},{"date":"2026-07-31","current":-4.027734,"twenty":-4.074133,"median":-3.637119,"eighty":-3.236722,"marketCap":742943690},{"date":"2026-08-07","current":-3.227486,"twenty":-4.048697,"median":-3.62524,"eighty":-3.239088,"marketCap":631063897},{"date":"2026-08-14","current":-3.773087,"twenty":-4.030809,"median":-3.711043,"eighty":-3.239088,"marketCap":737744133},{"date":"2026-08-21","current":-4.242245,"twenty":-4.248589,"median":-3.806921,"eighty":-3.244483,"marketCap":829477642},{"date":"2026-08-28","current":-4.458983,"twenty":-4.358015,"median":-3.881185,"eighty":-3.294301,"marketCap":871855939},{"date":"2026-09-04","current":-5.154129,"twenty":-4.410264,"median":-3.939688,"eighty":-3.344613,"marketCap":1007776575},{"date":"2026-09-11","current":-5.154129,"twenty":-4.552871,"median":-3.964844,"eighty":-3.358825,"marketCap":1007776575}],"updateTime":1789269371673},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":732397,"yearFounded":1999,"employeeNum":29,"address":"1405 Research Boulevard,Suite 125,Rockville,Maryland,United States","zipCode":"20850","officePhone":"240 243 8000","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.faeththerapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0652},{"period":"1month","weight":0.2743},{"period":"3month","weight":1.88},{"period":"6month","weight":0.1599},{"period":"1year","weight":3.0043},{"period":"ytd","weight":2.5089}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Faeth Therapeutics, Inc.是一家臨床階段的免疫療法公司，於2017年12月1日在特拉華州註冊成立。該公司是一家免疫腫瘤學公司，專註於癌症患者下一代療法的發現和開發。通過TMAb（腫瘤微環境激活生物製劑）平台，公司正在開發高選擇性療法，旨在在腫瘤微環境中選擇性地禁用免疫抑制信號或激活免疫刺激信號，以釋放T細胞對抗腫瘤。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.040355},{"month":2,"riseRate":0.6,"avgChangeRate":0.423412},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.06831},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.097622},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.09801},{"month":6,"riseRate":0.5,"avgChangeRate":0.03411},{"month":7,"riseRate":0.5,"avgChangeRate":-0.036531},{"month":8,"riseRate":0.5,"avgChangeRate":0.066301},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.025318},{"month":10,"riseRate":0,"avgChangeRate":-0.117074},{"month":11,"riseRate":0.4,"avgChangeRate":-0.031651},{"month":12,"riseRate":0.4,"avgChangeRate":0.005246}],"exchange":"NASDAQ","name":"Faeth Therapeutics","nameEN":"Faeth Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"FTH\",market:\"US\",,,undefined,":{"directors":[{"name":"Bob Holmen","position":"Director"},{"name":"Karen Vousden","position":"Director"},{"name":"Kristian Humer","position":"Director"},{"name":"Phillip B. Donenberg","position":"Director"},{"name":"Saira Ramasastry","position":"Director"},{"name":"Stephen M. Hahn","position":"Director"},{"name":"Thomas Ricks","position":"Director"}],"executives":[{"name":"Anand Parikh","position":"Chief Operating Officer"},{"name":"Josiah Craver","position":"Principal Financial and Accounting Officer and Senior Vice President of Finance"},{"name":"Brian Stephenson","position":"Head of Operations and Finance"},{"name":"Christopher W. Gerry","position":"General Counsel and President"}]}}}